Short answer
Cardiff Oncology, Inc. (CRDF) filed an 8-K current report with the SEC on May 14, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 financial results and business update announced for quarter ended March 31, 2026.
Cardiff Oncology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results and business update announced for quarter ended March 31, 2026
- Press release furnished as Exhibit 99.1, containing the substantive operating and financial details
- Investor focus: development progress, cash position, and funding runway disclosed in the accompanying release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cardiff Oncology, Inc. 8-K filings
Get the next CRDF 8-K as it lands
Follow CRDF for push alerts, or ask the research agent what this filing means.